• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Search
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    Author
    Sestak, I (88)
    Cuzick, J (70)Dowsett, M (52)Howell, A (22)Buus, R (20)Forbes, JF (15)Kronenwett, R (12)Ferree, S (11)Dubsky, P (9)Bonanni, B (8)... View MoreSubjectBreast cancer (9)breast cancer (5)Tamoxifen (5)Anastrozole (3)Aromatase inhibitors (3)Breast cancer risk (3)Prediction (3)adherence (2)aromatase inhibitors (2)Atypical hyperplasia (2)... View MoreDate Issued2021 (7)2020 (22)2019 (10)2018 (16)2017 (8)2016 (9)2015 (10)2014 (3)2013 (1)2012 (2)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 88

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer 

    Dowsett, M; Sestak, I; Buus, R; Lopez-Knowles, E; Mallon, E; Howell, A; Forbes, JF; Buzdar, A; Cuzick, J (2015-06-15)
    Thumbnail

    Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial 

    Mote, PA; Gompel, A; Howe, C; Hilton, HN; Sestak, I; Cuzick, J; Dowsett, M; Hugol, D; Forgez, P; Byth, K;... (2015-06)
    Thumbnail

    Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy 

    Buus, R; Sestak, I; Kronenwett, R; Denkert, C; Dubsky, P; Krappmann, K; Scheer, M; Petry, C; Cuzick, J; Dowsett, M (2016-11)
    Thumbnail

    Update on breast cancer risk prediction and prevention 

    Sestak, I; Cuzick, J (2015-02)
    Thumbnail

    Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer. 

    Buus, R; Yeo, B; Brentnall, AR; Klintman, M; Cheang, MCU; Khabra, K; Sestak, I; Gao, Q; Cuzick, J; Dowsett, M (2018-09-04)
    BACKGROUND: Several prognostic signatures for early oestrogen receptor-positive (ER+) breast cancer have been established with a 10-year follow-up. We tested the hypothesis that signatures optimised for 0-5-year and 5-10-year ...
    Thumbnail

    Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype 

    Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M;... (2015-08)
    Thumbnail

    Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5. 

    Dowsett, M; Sestak, I; Regan, MM; Dodson, A; Viale, G; Thürlimann, B; Colleoni, M; Cuzick, J (2018-07-01)
    Purpose Estimating risk of late distant recurrence (DR) is an important goal for managing women with hormone receptor-positive breast cancer after 5 years of endocrine treatment without recurrence. We developed and validated ...
    Thumbnail

    Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I) 

    Smith, SG; Sestak, I; Howell, A; Forbes, J; Cuzick, J (2017-08-10)
    Thumbnail

    Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine Therapy 

    Sestak, I (2017)
    Thumbnail

    EFFECT OF AROMATASE INHIBITION ON BONE DENSITY AND BONE TURNOVER IN HEALTHY POSTMENOPAUSAL WOMEN: RESULTS OF THE INTERNATIONAL BREAST CANCER INTERVENTION STUDY II (IBIS-II) 

    Eastell, R; Sestak, I; Gossiel, F; Patel, R; Blake, G; Coleman, R; Howell, A; Dowsett, M; Forbes, JF; Singh, S;... (2014-04)
    • 1
    • 2
    • 3
    • 4
    • . . .
    • 9
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.